In the last trading session, 79841.0 Hookipa Pharma Inc (NASDAQ:HOOK) shares changed hands as the company’s beta touched 0.69. With the company’s per share price at $1.90 changed hands at -$0.13 or -6.65% during last session, the market valuation stood at $19.60M. HOOK’s last price was a discount, traded about -452.63% off its 52-week high of $10.50. The share price had its 52-week low at $1.88, which suggests the last value was 1.05% up since then. When we look at Hookipa Pharma Inc’s average trading volume, we note the 10-day average is 66610.0 shares, with the 3-month average coming to 52.61K.
Analysts gave the Hookipa Pharma Inc (HOOK) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.50. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended HOOK as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Hookipa Pharma Inc (NASDAQ:HOOK) trade information
Instantly HOOK was in red as seen at the end of in last trading. With action -7.04%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -75.56%, with the 5-day performance at -7.04% in the red. However, in the 30-day time frame, Hookipa Pharma Inc (NASDAQ:HOOK) is -7.91% down. Looking at the short shares, we see there were 36244.0 shares sold at short interest cover period of 1.08 days.
The consensus price target for the stock as assigned by Wall Street analysts is 3, meaning bulls need an upside of 36.67% from its current market value. According to analyst projections, HOOK’s forecast low is 3 with 3 as the target high. To hit the forecast high, the stock’s price needs a -57.89% plunge from its current level, while the stock would need to soar -57.89% for it to hit the projected low.
The 2024 estimates are for Hookipa Pharma Inc earnings to increase by 71.63%, but the outlook for the next 5-year period is at 14.50% per year.
HOOK Dividends
Hookipa Pharma Inc is expected to release its next quarterly earnings report in January.
Hookipa Pharma Inc (NASDAQ:HOOK)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 21.44% of Hookipa Pharma Inc shares while 37.16% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 47.30%. There are 37.16% institutions holding the Hookipa Pharma Inc stock share, with ECOR1 CAPITAL, LLC the top institutional holder. As of 2024-06-30, the company held 4.5597% of the shares, roughly 5.72 million HOOK shares worth $3.38 million.
ARTAL GROUP S.A. holds the second largest percentage of outstanding shares, with 4.5191% or 5.67 million shares worth $3.35 million as of 2024-06-30.
